Search clinical trials for: Refractory primary open angle glaucoma

Total 33991 results

American Society Of Thermalism And Climatology Inc

Unknown

Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. (GME)

Primary Open Angle Glaucoma | Hypertension Ocular

United States
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

Ocular Hypertension | Open Angle Glaucoma

Japan
Glaukos Corporation

Completed

A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma (SY)

Glaucoma | Glaucoma, Open-Angle | Eye Diseases

Spain, France, Armenia, Germany, Austria, Italy
Glaukos Corporation

Completed

Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) (SL)

Glaucoma | Glaucoma, Open-Angle | Eye Diseases

Spain, France, Austria, Italy, Armenia, Germany, Greece, Poland, United Kingdom
Sensimed AG
Clinique Monchoisi

Terminated

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy With Collagen Implant

Primary Open Angle Glaucoma

Switzerland
Dr. Anton Hommer

Completed

An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More

Primary Open Angle Glaucoma | Ocular Hypertension

Austria
Mario Negri Institute for Pharmacological Research

Completed

Multicentric Observational Study on Quality of Life in Glaucoma

Primary Open-angle Glaucoma

Italy
University Hospital, Basel, Switzerland

Withdrawn

Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma

Primary Open Angle Glaucoma

Switzerland
Maisonneuve-Rosemont Hospital

Completed

Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma

Glaucoma, Open-Angle

Canada
Centro Hospitalar do Baixo Vouga

Unknown

Posterior Cornea in Primary Open Angle Glaucoma

Glaucoma

Portugal
Amakem, NV

Completed

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma | Eye Disease

United States
Merck Sharp & Dohme LLC

Completed

Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma

Ocular Hypertension | Open Angle Glaucoma
Vasan Eye Care Hospital

Completed

Structure Function Correlation in Primary Open Angle Glaucoma (STR_FN)

Primary Open Angle Glaucoma

India
ForSight Vision5, Inc.

Completed

A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

Latvia
Daniel Moore
Pfizer

Terminated

Safety Study of Latanoprost Slow Release Insert (Latanoprost SR)

Primary Open Angle Glaucoma (POAG) | Ocular Hypertension (OHT)

United States
University Hospital, Grenoble

Completed

PIO Laser Sclerectomy IOP SLT Sclerectomy (PIO laser SPNP)

Primary Open-Angle Glaucoma

France
Medical University of Vienna

Completed

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Physiology | Retina

Austria
Alleanza Pharmaceuticals, Inc.

Completed

Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

Primary Open Angle Glaucoma | Ocular Hypertension | Elevated Intraocular Pressure

United States
Carmel Medical Center

Unknown

Genetic Testing in Primary Congenital Glaucoma Patients

Congenital Glaucoma

Israel
Allergan

Completed

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Mexico, Colombia
Meir Medical Center

Completed

EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA (ETSG)

Primary Open Angle Glaucoma

Israel
Allergan

Completed

Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-Angle Glaucoma

United States
Allergan

Completed

A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension (APOTUS)

Ocular Hypertension | Glaucoma, Open-Angle

China
Allergan

Completed

A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension (LOTUSDI)

Ocular Hypertension | Glaucoma, Open-Angle

China
Allergan

Completed

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Germany, Netherlands
Allergan

Completed

A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

Austria
Sensimed AG

Withdrawn

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy

Primary Open Angle Glaucoma

France
Aristotle University Of Thessaloniki

Completed

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Primary Open Angle Glaucoma | Ocular Hypertension

Greece
Aristotle University Of Thessaloniki

Completed

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

Primary Open Angle Glaucoma | Exfoliation Syndrome

Greece
Aristotle University Of Thessaloniki

Completed

24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination

Glaucoma

Greece
Allergan

Completed

Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Switzerland
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-angle Glaucoma

United States
Xiaodong Zhou

Completed

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients

Primary Open-angle Glaucoma
Allergan

Completed

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Ocular Hypertension | Glaucoma, Open-Angle

Korea, Republic of
Sensimed AG

Completed

Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor

Primary Open Angle Glaucoma | Healthy Subjects

United States
Agency for Healthcare Research and Quality (AHRQ)
Jules Stein Eye Institute; American Academy of Ophthalmology

Completed

Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma (RiGOR)

Open Angle Glaucoma

United States
University of Erlangen-Nürnberg Medical School
German Research Foundation

Unknown

Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma

Primary Open Angle Glaucoma | Ocular Hypertension | Secondary Open Angle Glaucoma

Germany
University of Campinas, Brazil

Completed

Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG

Uveitis, Anterior | Cystoid Macular Edema

Brazil
Alcon Research

Terminated

Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil

Glaucoma

Brazil
Allergan

Completed

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

A Study of LUMIGAN® RC in the Clinical Setting

Ocular Hypertension | Glaucoma, Primary Open Angle

Canada
Allergan

Completed

Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Open-Angle Glaucoma

Belgium
Amakem, NV

Completed

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Ocular Hypertension | Glaucoma | Eye Disease

United States
Alcon Research

Completed

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Glaucoma

United States
University of Sao Paulo General Hospital

Completed

Transconjunctival Needling Revision Versus Medical Treatment

Primary Open Angle Glaucoma

Brazil
Alcon Research

Terminated

Study of TRAVATAN in Subjects With Iris Pigmentation Changes

Ocular Hypertension | Open-Angle Glaucoma
Azienda Socio Sanitaria Territoriale degli Spedali...
Aristotle University Of Thessaloniki

Completed

Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) (SAF-24H-IOP)

Primary Open Angle Glaucoma | Ocular Hypertension

Greece, Italy
Universitaire Ziekenhuizen KU Leuven

Unknown

Correlation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle Glaucoma

Primary Open Angle Glaucoma | Normal Tension Glaucoma

Belgium
Pfizer

Completed

Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic (NAP)

Pain

Brazil, Costa Rica, Chile, Ecuador, Honduras, Peru
Allergan S.A. DE C.V..

Completed

Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Glaucoma Primary Open Angle

Mexico

3

Subscribe